You have Guest access.
Log In
LETTER TO THE EDITORS
Isabel Bosca, Maria Bosca, Antonio Belenguer, Monserrat Evole, Miguel Hernandez, Bonaventura Casanova and Francisco Coret
Journal Article
Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis
Jason Ramtahal, Anu Jacob, Kumar Das and Mike Boggild
Journal of Neurology, 2006, Volume 253, Number 9, Pages 1160-1164
Glatiramer acetate versus interferon beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients
Jane Castelli-Haley, Merry-Kay A. Oleen-Burkey, Maureen J. Lage and Kenneth P. Johnson
Advances in Therapy, 2008, Volume 25, Number 7, Pages 658-673
Book Chapter
Neuroprotective Effects of Interferon-β in Multiple Sclerosis
Fabrizio Giuliani, Rana Zabad and V. Wee Yong
Current Clinical Neurology, 2005, Inflammatory Disorders of the Nervous System, Pages 133-145
Immunological assay for assessing the efficacy of glatiramer acetate (Copaxone) in multiple sclerosis A pilot study
Cinthia Farina, Stefan Wagenpfeil and Reinhard Hohlfeld
Journal of Neurology, 2002, Volume 249, Number 11, Pages 1587-1592
The search for a balance between short and long-term treatment outcomes in multiple sclerosis
Ulf Baumhackl
Journal of Neurology, 2008, Volume 255, Supplement 1, Pages 75-83
Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis
Jane Castelli-Haley, MerriKay A. Oleen-Burkey, Maureen J. Lage and Kenneth P. Johnson
Advances in Therapy, 2009, Volume 26, Number 5, Pages 552-562
Combination therapies in multiple sclerosis
Ralf Gold
Journal of Neurology, 2008, Volume 255, Supplement 1, Pages 51-60
Disease-modifying drugs in multiple sclerosis: a review of expenditure in Ireland
B. Bailey
Irish Journal of Medical Science, 2011, Volume 180, Number 2, Pages 337-341
Lipoatrophy: a non–reversible complication of subcutaneous interferon–beta 1a treatment of multiple sclerosis
A. G. Beiske and K.-M. Myhr
Journal of Neurology, 2006, Volume 253, Number 3, Pages 377-378
Clinical Aspects of Immunogenicity to Biopharmaceuticals
Simona Malucchi and Antonio Bertolotto
Biotechnology: Pharmaceutical Aspects, 1, Volume VIII, Immunogenicity of Biopharmaceuticals, Pages 27-56
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info